Author

Ceren Kütahya

University of OxfordORCID 0000-0002-8680-6536Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:rat· 1

Frequent Co-Authors

David J. PeeleriD· 2 shared Giulia BrachiiD· 2 shared Jonathan YeowiD· 2 shared Molly M. StevensiD· 2 shared Patrick PeschkeiD· 2 shared Thomas F. F. Fernandez DebetsiD· 2 shared Adrian NajeriD· 1 shared Alejandro Suárez‐BonnetiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

David J. PeelerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An injectable soft implant for long-acting, reversible, ultra-stable release of therapeutics

Ceren Kütahya, Luca Panariello, Adrian Najer, Tatiana Rizou, André Shamsabadi, Giulia Brachi, David J. Peeler, Lukeriya Zharova, Thomas F. F. Fernandez Debets, Patrick Peschke, Anna P. Constantinou, Ruoxiao Xie, Yuxi Cheng, Ross Burdis, Alejandro Suárez‐Bonnet, , Molly M. Stevens

This paper develops an injectable hydrogel platform with poly(orthoester) microparticles for long-term, zero-order drug release, demonstrating in vitro and in vivo efficacy for up to 12 months.

bioRxiv · Feb 26, 2026 · PreprintBioengineering

Nanoscale biodegradable printing for designed tuneability of vaccine delivery kinetics

David J. Peeler, Rujie Sun, Ceren Kütahya, Patrick Peschke, Kun Li Zhou, Giulia Brachi, Jonathan Yeow, Omar Rifaie‐Graham, Jonathan P. Wojciechowski, Thomas F. F. Fernandez Debets, Vernon LaLone, Xin Song, Krunal Polra, Paul F. McKay, John S. Tregoning, , Molly M. Stevens

This paper develops a 3D printing method to create tunable drug delivery systems that control vaccine-induced antibody responses.

Advanced Materials · Feb 28, 2025Peer-reviewedBioengineering